On Invalid Date, Abbott Laboratories (NYSE: ABT) reported Q1 2024 earnings per share (EPS) of $0.70, up 6.67% year over year. Total Abbott Laboratories earnings for the quarter were $1.23 billion. In the same quarter last year, Abbott Laboratories's earnings per share (EPS) was $0.75.
As of Q2 2024, Abbott Laboratories's earnings has grown -2.42% year over year. This is 510.51 percentage points lower than the US Medical Devices industry earnings growth rate of 508.09%. Abbott Laboratories's earnings in the past year totalled $5.63 billion.
What was ABT's revenue last quarter?
On Invalid Date, Abbott Laboratories (NYSE: ABT) reported Q1 2024 revenue of $9.96 billion up 2.23% year over year. In the same quarter last year, Abbott Laboratories's revenue was $9.75 billion.
What was ABT's revenue growth in the past year?
As of Q2 2024, Abbott Laboratories's revenue has grown -2.84% year over year. This is 13.42 percentage points lower than the US Medical Devices industry revenue growth rate of 10.58%. Abbott Laboratories's revenue in the past year totalled $40.33 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.